1、Zhang C, Liu J*, Tong J, Sun X, Song S, Huang G. 18F-FDG-PET evaluation ofpathological tumour response to neoadjuvant therapy in patients with NSCLC. Nucl Med Commun,2012;279(20):3898-910.
2、Sheng SL, Liu JJ*, Dai YH, Sun XG, Xiong XP, Huang G. Knockdown of lactatedehydrogenase?A suppresses tumor growth and metastasis of human hepatocellularcarcinoma. FEBS J.,2012;279(20):3898-910.
3、Xue H, Liu J*, Lin B, Wang Z, Sun J, Huang G.. A meta-analysis of interleukin-8 -251 promoter polymorphism associated with gastric cancer risk.. PLoS One,2012;7(1):280-83
4、Li R, Liu J*, Xue H, Huang G. Diagnostic value of fecal tumor M2-pyruvate kinase for CRC screening: a systematic review and meta-analysis.. Int J Cancer,2012;131(8):1837-45
5、许远帆 刘华 刘建军 . 18F-FDG PET/CT在基于不同影像的肺孤立性结节中的诊断效率比较. 重庆医学,2011;8（3):769-770
|
